Arrowhead Pharmaceuticals, Inc.

SCHRODER INVESTMENT MANAGEMENT GROUP ARWR

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/14/2026

Shares

162,005

Value ($000)

9,340

Weight

0.0%

2020 Q1 - 2026 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/14/2026	9,340	0.0%	162,005	3/31/2026
2025 Q1	5/13/2025	2,282	0.0%	165,122	3/31/2025
2024 Q4	2/12/2025	3,835	0.0%	206,070	12/31/2024
2024 Q3	11/13/2024	4,102	0.0%	208,560	9/30/2024
2024 Q2	8/12/2024	1,439	0.0%	55,349	6/30/2024
2024 Q1	5/14/2024	1,599	0.0%	55,892	3/31/2024
2023 Q4	2/14/2024	4,510	0.0%	147,398	12/31/2023
2023 Q3	11/14/2023	4,954	0.0%	184,366	9/30/2023
2023 Q2	8/11/2023	6,489	0.0%	181,962	6/30/2023
2023 Q1	5/11/2023	4,622	0.0%	181,962	3/31/2023
2022 Q4	2/10/2023	7,380	0.0%	181,962	12/31/2022
2022 Q3	11/14/2022	5,803	0.0%	175,592	9/30/2022
2022 Q2	8/11/2022	3,772	0.0%	107,115	6/30/2022
2022 Q1	5/16/2022	8,339	0.0%	182,904	3/31/2022
2021 Q4	2/14/2022	6,105	0.0%	92,085	12/31/2021
2021 Q3	11/12/2021	4,310	0.0%	69,036	9/30/2021
2021 Q2	8/13/2021	4,256	0.0%	51,392	6/30/2021
2021 Q1	5/28/2021	3,753	0.0%	56,599	3/31/2021
2020 Q4	2/16/2021	5,227	0.0%	68,118	12/31/2020
2020 Q3	11/13/2020	2,957	0.0%	67,484	9/30/2020
2020 Q2	8/13/2020	3,002	0.0%	69,497	6/30/2020
2020 Q1	5/15/2020	2,011	0.0%	69,497	3/31/2020